Journal of Virology and Infectious Diseases

Volume 2, Issue 1 (2021)

Research Article - Open Access
In Silico Analysis and Computational Assessment of Potential Inhibitors of SARS-Cov-2 Main Protease

1. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol Biol Rev. 2005;69(4):635-64. 

2. Choi KW, Chau TN, Tsang O, Tso E. Characteristics and outcomes of patients with severe acute respiratory syndrome (SARS) in Hong Kong. Ann Intern Med. 2003;139(9):I15. 

3. Ziebuhr J. Molecular biology of severe acute respiratory syndrome coronavirus. Curr Opin Microbiol. 2004;7(4):412-9. 

4. Abdul-Rasool S, Fielding BC. Understanding human coronavirus HCoV-NL63. Open Virol J. 2010;4:76.

5. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368-73. 

6. Imbert I, Snijder EJ, Dimitrova M, Guillemot JC, Lécine P, Canard B. The SARS-Coronavirus PLnc domain of nsp3 as a replication/ transcription scaffolding protein. Virus Res. 2008;133(2):136-48. 

7. Araf Y, Faruqui NA, Anwar S, Hosen MJ. SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol. 2020; 24:1-6. 

8. Zhu Y, Li C, Chen L, Xu B, Zhou Y, Cao L, et al. A novel human coronavirus OC43 genotype detected in mainland China. Emerg Microbes Infect. 2018;7(1):1-4. 

9. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A. The genome sequence of the SARS-associated coronavirus. Science. 2003;300(5624):1399-404